Major Depression

Title	Average Rating
Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression	100.00%
A systematic literature review of clinical trials and therapeutic applications of ibogaine	100.00%
Iboga – The Antidote to Mind Control?	100.00%
Antidepressant Use Prospectively Relates to a Poorer Long-Term Outcome of Depression: Results from a Prospective Community Cohort Study over 30 Years	100.00%
Low-dose naltrexone for disease prevention and quality of life.	95.00%
A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department.	90.00%
Lipidomics: the function of vital lipids in embryogenesis preventing autism spectrum disorders, treating sterile inflammatory di	80.00%
Low dosage lithium augmentation in venlafaxine resistant depression: An open-label study.	80.00%
Anterior Cingulate Desynchronization and Functional Connectivity with the Amygdala During a Working Memory Task Predict Rapid An	80.00%
The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder.	80.00%
Ketamine in the treatment of Depression	70.00%
Increased risk of cancer subsequent to severe depression--a nationwide population-based study.	70.00%
Increased Response to Ketamine Following Treatment at Long Intervals: Implications for Intermittent Use.	60.00%
MIKAEL NORDFORS WFA COPENHAGEN RALLY 2021
Ketamine for suicidality: an umbrella review

Languages